Search research articles
Contact Us
Filters
Showing results (151-160 of 183) with videos related to
Page
of 19
Sort By:
Journal of the American Heart Association
|
December 21, 2018
Adjudicated Heart Failure in HIV-Infected and Uninfected Men and Women
Matthew J Feinstein, Alexandra B Steverson, Hongyan Ning, et al.
Global Heart
|
April 23, 2016
Training and Capacity Building in LMIC for Research in Heart and Lung Diseases: The NHLBI-UnitedHealth Global Health Centers of Excellence Program
Gerald S Bloomfield, Denis Xavier, Deshirée Belis, et al.
Journal of the American Heart Association
|
December 11, 2025
Baseline ECG and Cardiovascular Outcomes in People With HIV: Insights From REPRIEVE
Aya Awwad, Christopher de Filippi, Heather Ribaudo, et al.
AIDS (London, England)
|
July 25, 2022
Diet in a global cohort of adults with HIV at low-to-moderate traditional cardiovascular disease risk
Kathleen V Fitch, Sara A McCallum, Kristine M Erlandson, et al.
The Lancet. HIV
|
June 7, 2025
Effects of antiretrovirals on major adverse cardiovascular events in the REPRIEVE trial: a longitudinal cohort analysis
Carl J Fichtenbaum, Carlos D Malvestutto, Maya G Watanabe, et al.
Circulation. Heart Failure
|
December 29, 2025
Heart Failure Risk and Events in People With HIV: The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)
Gerald S Bloomfield, Maya Watanabe, Sara McCallum, et al.
The Lancet. HIV
|
January 20, 2025
Performance of the pooled cohort equations and D:A:D risk scores among individuals with HIV in a global cardiovascular disease prevention trial: a cohort study leveraging data from REPRIEVE
Steven K Grinspoon, Markella V Zanni, Virginia A Triant, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 19, 2024
Pitavastatin Is Well-Tolerated With no Detrimental Effects on Physical Function
Kristine M Erlandson, Triin Umbleja, Heather J Ribaudo, et al.
AIDS (London, England)
|
June 18, 2025
No evidence of a detrimental effect of pitavastatin on neurocognitive function among people with HIV
Kristine M Erlandson, Ashley McKhann, Douglas W Kitch, et al.
The Lancet. HIV
|
April 3, 2025
Statin effects on the incidence of major non-cardiovascular disease events among a global cohort of people with HIV: a randomised controlled trial
Marissa R Diggs, Triin Umbleja, Sara McCallum, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 183) with videos related to
Sort By:
Page
of 19
Journal of the American Heart Association
|
December 21, 2018
Adjudicated Heart Failure in HIV-Infected and Uninfected Men and Women
Matthew J Feinstein, Alexandra B Steverson, Hongyan Ning, et al.
Global Heart
|
April 23, 2016
Training and Capacity Building in LMIC for Research in Heart and Lung Diseases: The NHLBI-UnitedHealth Global Health Centers of Excellence Program
Gerald S Bloomfield, Denis Xavier, Deshirée Belis, et al.
Journal of the American Heart Association
|
December 11, 2025
Baseline ECG and Cardiovascular Outcomes in People With HIV: Insights From REPRIEVE
Aya Awwad, Christopher de Filippi, Heather Ribaudo, et al.
AIDS (London, England)
|
July 25, 2022
Diet in a global cohort of adults with HIV at low-to-moderate traditional cardiovascular disease risk
Kathleen V Fitch, Sara A McCallum, Kristine M Erlandson, et al.
The Lancet. HIV
|
June 7, 2025
Effects of antiretrovirals on major adverse cardiovascular events in the REPRIEVE trial: a longitudinal cohort analysis
Carl J Fichtenbaum, Carlos D Malvestutto, Maya G Watanabe, et al.
Circulation. Heart Failure
|
December 29, 2025
Heart Failure Risk and Events in People With HIV: The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)
Gerald S Bloomfield, Maya Watanabe, Sara McCallum, et al.
The Lancet. HIV
|
January 20, 2025
Performance of the pooled cohort equations and D:A:D risk scores among individuals with HIV in a global cardiovascular disease prevention trial: a cohort study leveraging data from REPRIEVE
Steven K Grinspoon, Markella V Zanni, Virginia A Triant, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 19, 2024
Pitavastatin Is Well-Tolerated With no Detrimental Effects on Physical Function
Kristine M Erlandson, Triin Umbleja, Heather J Ribaudo, et al.
AIDS (London, England)
|
June 18, 2025
No evidence of a detrimental effect of pitavastatin on neurocognitive function among people with HIV
Kristine M Erlandson, Ashley McKhann, Douglas W Kitch, et al.
The Lancet. HIV
|
April 3, 2025
Statin effects on the incidence of major non-cardiovascular disease events among a global cohort of people with HIV: a randomised controlled trial
Marissa R Diggs, Triin Umbleja, Sara McCallum, et al.
Page
of 19